HOME >> BIOLOGY >> NEWS
Scientists find new agent to fight genetic disorders -- Zorro-Locked Nucleic Acid

A study to appear in the June 2007 issue of The FASEB Journal describes a new agent, called "Zorro-LNA," which has the potential to stop genetic disorders in their tracks. In the study, researchers from the Karolinska Institute in Stockholm, Sweden, describe how they developed Zorro-LNA to bind with both strands of a genes DNA simultaneously, effectively disabling that gene. This development has clinical implications for virtually every human condition caused by or worsened by dominant defective genes. Examples include: Huntingtons disease, familial high cholesterol, polycystic kidney disease, some instances of glaucoma and colorectal cancer, and neurofibromatosis, among others.

"Zorro-LNA is a new substance that targets DNA and turns off genes," said co-author Edvard Smith of the Karolinska Institute in Sweden. "It has the potential of becoming a new drug for the treatment of human genetic disease."

The findings described in this article significantly raise the possibility that new therapies could arise where defective DNA is deactivated more completely and more thoroughly than ever before. For instance, Zorro-LNA could be used in combination with "RNA interference" (RNAi). Like Zorro-LNA, RNAi has the ability to deactivate genes, but does so by degrading the genes RNA. In addition, Zorro-LNA could be used to deactivate certain genes in stem cells, which could eventually lead to the development of new cells, tissues, or organs. The discovery of RNAi was recognized by a Nobel Prize award in 2006 to two American scientists.

"This is a major development in the treatment not only of genetic diseases, but also of acquired diseases when microbes or toxins cause genes to go awry" said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "One might say these researchers have found a gene-hunters Holy Grail for which scientists have been hunting for many years. Zorro-LNA should give us a new, safe way of blocking the effects of er
'"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
30-Apr-2007


Page: 1 2

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2019)... ... September 25, 2019 , ... The esteemed dental ... 20,000 dental implants for a variety of procedures, including single tooth replacement, new ... implants. Dental implants offer patients permanent tooth replacement solutions that look ...
(Date:9/24/2019)... CAMBRIDGE, Mass. (PRWEB) , ... September 23, 2019 ... ... with US offices in Cambridge, MA, announce today that Holotype HLA and other ... the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) ...
(Date:9/22/2019)... ... September 20, 2019 , ... ... adjusting to client demands for precision medicine products. The report, Lab Instrumentation ... billion in 2018, the pharma/bio sector is the largest source of demand for ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... , ... October 10, 2019 , ... ... the largest network of clinical research centers in Europe. All Pratia research centers ... in Europe to become trained and certified as Virtual Trial Capable and prepared ...
(Date:10/3/2019)... ... 2019 , ... Today Cereset®, the only proven non-invasive technology ... its randomized research trial for individuals with persisting symptoms following mild-Traumatic Brain Injury ... non-invasive technology which compares tones delivered to a subject’s brain guided by the ...
(Date:10/3/2019)... ... ... eKare’s inSight® digital 3D imaging and wound measurement system has been selected ... Health Science Network (EMAHSN), the innovation arm of the NHS. The program was designed ... and deploy solutions to the most pressing challenges facing the NHS. , The ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... area of high-level X-ray methods using synchrotron-produced X-rays to study amorphous drug ... will present “Synchrotron X-Ray Diffraction and Pair Distribution Function Analysis of Drug/Polymer ...
Breaking Biology Technology:
Cached News: